Immunotherapy in first line for extensive-stage small-cell lung cancer: another piece is going to fill the puzzle?

Autor Passiglia, Francesco, Novello, Silvia
Vydáno v Ann Transl Med (2018)

Targeting chimeras fusion proteins in non-small cell lung cancer: where are we going?

Autor Passiglia, Francesco, Novello, Silvia
Vydáno v Transl Lung Cancer Res (2020)

Five-year overall survival of pembrolizumab in advanced non-small cell lung cancer: another step from care to cure?

Autor Bironzo, Paolo, Passiglia, Francesco, Novello, Silvia
Vydáno v Ann Transl Med (2019)

Moving osimertinib to first-line: the right “strategy” in the chessboard of epidermal growth factor receptor-mutated non-small cell lung cancer?

Autor Passiglia, Francesco, Raez, Luis E., Rolfo, Christian
Vydáno v J Thorac Dis (2018)

First-line immune-chemotherapy combination: the right strategy to fight squamous non-small cell lung cancer?

Autor Passiglia, Francesco, Bironzo, Paolo, Scagliotti, Giorgio V.
Vydáno v Transl Lung Cancer Res (2019)

Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon?

Autor Passiglia, Francesco, Reale, Maria Lucia, Cetoretta, Valeria, Novello, Silvia
Vydáno v Immunotargets Ther (2021)

Improving lung cancer outcomes through smoking cessation: the Women Against Lung Cancer in Europe (WALCE) experience

Autor Capelletto, Enrica, Passiglia, Francesco, Ferraresi, Federica, Vallone, Stefania, Novello, Silvia
Vydáno v J Thorac Dis (2020)

Is there any place for immune-checkpoint inhibitors in the treatment algorithm of fusion-driven non-small cell lung cancer?—a literature review

Autor Leone, Gianmarco, Passiglia, Francesco, Bironzo, Paolo, Bertaglia, Valentina, Novello, Silvia
Vydáno v Transl Lung Cancer Res (2020)

Exploring the immune-checkpoint inhibitors’ efficacy/tolerability in special non-small cell lung cancer (NSCLC) populations: focus on steroids and autoimmune disease

Autor Passiglia, Francesco, Cetoretta, Valeria, De Filippis, Marco, Napoli, Valerio, Novello, Silvia
Vydáno v Transl Lung Cancer Res (2021)

Immune checkpoint inhibitors in lung cancer: the holy grail has not yet been found…

Autor Thungappa, Satheesh, Ferri, Jose, Caglevic, Christian, Passiglia, Francesco, Raez, Luis, Rolfo, Christian
Vydáno v ESMO Open (2017)

Vaccine and immune cell therapy in non-small cell lung cancer

Autor Oliveres, Helena, Caglevic, Christian, Passiglia, Francesco, Taverna, Simona, Smits, Evelien, Rolfo, Christian
Vydáno v J Thorac Dis (2018)

Potential Role of ANGPTL4 in the Cross Talk between Metabolism and Cancer through PPAR Signaling Pathway

Autor La Paglia, Laura, Listì, Angela, Caruso, Stefano, Amodeo, Valeria, Passiglia, Francesco, Bazan, Viviana, Fanale, Daniele
Vydáno v PPAR Res (2017)

Second-Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological, and Molecular Aspects of Nintedanib

Autor Corrales, Luis, Nogueira, Amanda, Passiglia, Francesco, Listi, Angela, Caglevic, Christian, Giallombardo, Marco, Raez, Luis, Santos, Edgardo, Rolfo, Christian
Vydáno v Front Med (Lausanne) (2017)

Multisciplinary management of patients with liver metastasis from colorectal cancer

Autor De Greef, Kathleen, Rolfo, Christian, Russo, Antonio, Chapelle, Thiery, Bronte, Giuseppe, Passiglia, Francesco, Coelho, Andreia, Papadimitriou, Konstantinos, Peeters, Marc
Vydáno v World J Gastroenterol (2016)

Nintedanib in NSCLC: evidence to date and place in therapy

Autor Bronte, Giuseppe, Passiglia, Francesco, Galvano, Antonio, Barraco, Nadia, Listì, Angela, Castiglia, Marta, Rizzo, Sergio, Fiorentino, Eugenio, Bazan, Viviana, Russo, Antonio
Vydáno v Ther Adv Med Oncol (2016)

PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis

Autor Passiglia, Francesco, Bronte, Giuseppe, Bazan, Viviana, Natoli, Clara, Rizzo, Sergio, Galvano, Antonio, Listì, Angela, Cicero, Giuseppe, Rolfo, Christian, Santini, Daniele, Russo, Antonio
Vydáno v Oncotarget (2016)

The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis

Autor Passiglia, Francesco, Rizzo, Sergio, Di Maio, Massimo, Galvano, Antonio, Badalamenti, Giuseppe, Listì, Angela, Gulotta, Leonardo, Castiglia, Marta, Fulfaro, Fabio, Bazan, Viviana, Russo, Antonio
Vydáno v Sci Rep (2018)

Publisher Correction: The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis

Autor Passiglia, Francesco, Rizzo, Sergio, Di Maio, Massimo, Galvano, Antonio, Badalamenti, Giuseppe, Listì, Angela, Gulotta, Leonardo, Castiglia, Marta, Fulfaro, Fabio, Bazan, Viviana, Russo, Antonio
Vydáno v Sci Rep (2018)

New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?

Autor Bronte, Giuseppe, Silvestris, Nicola, Castiglia, Marta, Galvano, Antonio, Passiglia, Francesco, Sortino, Giovanni, Cicero, Giuseppe, Rolfo, Christian, Peeters, Marc, Bazan, Viviana, Fanale, Daniele, Giordano, Antonio, Russo, Antonio
Vydáno v Oncotarget (2015)

Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients

Autor Passiglia, Francesco, Galvano, Antonio, Castiglia, Marta, Incorvaia, Lorena, Calò, Valentina, Listì, Angela, Mazzarisi, Salvatore, Perez, Alessandro, Gallina, Giuseppe, Rizzo, Sergio, Soto Parra, Hector, Bazan, Viviana, Russo, Antonio
Vydáno v Ther Adv Med Oncol (2019)